Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
18 pending office actions • 11 art units • 17 examiners • 0 of 18 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (17%) |
| §103 only | 3 (17%) |
| §102 only | 1 (6%) |
| §112 only | 1 (6%) |
| Double-patenting + other | 5 (28%) |
| Multi-statute (no §101) | 5 (28%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RONEY, CELESTE A | 2 | 62.8% | +17.5% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| PORTILLO, JAIRO H | 1 | 53.5% | +31.1% |
| BAEK, BONG-SOOK | 1 | 41.7% | +69.9% |
| ALSOMAIRY, SARAH ABDOALATIF | 1 | 57.8% | +30.2% |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
| CROW, ROBERT THOMAS | 1 | 41.7% | +32.7% |
| OGLES, MATTHEW ERIC | 1 | 50.0% | +57.0% |
| NGUYEN, JOHN P | 1 | 43.9% | +41.8% |
| PAK, JOHN D | 1 | 52.4% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18211108 | Apparatus, Systems and Methods for Predicting, Screening and Monitoring of Encephalopathy/Delirium | OGLES, MATTHEW ERIC | 133d overdue |
| 18434313 | SIMULTANEOUS AND CONTINUOUS MEASUREMENT OF OTOACOUSTIC EMISSIONS ACROSS LEVEL AND FREQUENCY | PORTILLO, JAIRO H | 17d overdue |
| 17503082 | MONITORING EFFICACY OF MAGNETIC AND ELECTRIC FIELDS USING BIOMARKERS | REDDY, SUNITA | 5d |
| 18572054 | SUSTAINED RELEASE FORMULATIONS COMPRISING A SELECTIVE ANDROGEN RECEPTOR MODULATOR | BAEK, BONG-SOOK | 22d |
| 18262970 | CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES | MCMILLIAN, KARA RENITA | — |
| 18256593 | COMPOSITIONS COMPRISING MOLECULES FOR CYSTIC FIBROSIS TREATMENT | NGUYEN, JOHN P | — |
| 18032768 | METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE | PAK, JOHN D | — |
| 18120204 | MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF | MEYERING, SHABANA SHABBEER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18211108 | Apparatus, Systems and Methods for Predicting, Screening and Monitoring of Encephalopathy/Delirium | OGLES, MATTHEW ERIC | 133d overdue |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | ALSOMAIRY, SARAH ABDOALATIF | 23d overdue |
| 18434313 | SIMULTANEOUS AND CONTINUOUS MEASUREMENT OF OTOACOUSTIC EMISSIONS ACROSS LEVEL AND FREQUENCY | PORTILLO, JAIRO H | 17d overdue |
| 18223765 | OPTOELECTRONIC CARTRIDGE FOR CANCER BIOMARKER DETECTION UTILIZING SILICON NANOWIRE ARRAYS | CROW, ROBERT THOMAS | 16d overdue |
| 18572054 | SUSTAINED RELEASE FORMULATIONS COMPRISING A SELECTIVE ANDROGEN RECEPTOR MODULATOR | BAEK, BONG-SOOK | 22d |
| 18896069 | COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES | DONOHUE, SEAN R | — |
| 18886316 | GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS | RONEY, CELESTE A | — |
| 18886318 | GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS | RONEY, CELESTE A | — |
| Art Unit | Apps |
|---|---|
| 3791 | 4 |
| 1618 | 2 |
| 1611 | 1 |
| 1646 | 1 |
| 1623 | 1 |
| 1683 | 1 |
| 1619 | 1 |
| 1699 | 1 |
| 1635 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18896069 | COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES | DONOHUE, SEAN R | 1618 | §102§103§112DP | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18886316 | GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS | RONEY, CELESTE A | — | §103DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18886318 | GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS | RONEY, CELESTE A | — | §103§112DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18434313 | SIMULTANEOUS AND CONTINUOUS MEASUREMENT OF OTOACOUSTIC EMISSIONS ACROSS LEVEL AND FREQUENCY | PORTILLO, JAIRO H | 3791 | §101§103 | Final Rejection | 17d overdue | Pending | Feb 06, 2024 |
| 18572054 | SUSTAINED RELEASE FORMULATIONS COMPRISING A SELECTIVE ANDROGEN RECEPTOR MODULATOR | BAEK, BONG-SOOK | 1611 | §103§112 | Final Rejection | 22d | Pending | Dec 19, 2023 |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §112 | Final Rejection | 23d overdue | Pending | Aug 29, 2023 |
| 18262970 | CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES | MCMILLIAN, KARA RENITA | 1623 | §103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18223765 | OPTOELECTRONIC CARTRIDGE FOR CANCER BIOMARKER DETECTION UTILIZING SILICON NANOWIRE ARRAYS | CROW, ROBERT THOMAS | 1683 | §103DP | Non-Final OA | 16d overdue | Pending | Jul 19, 2023 |
| 18211108 | Apparatus, Systems and Methods for Predicting, Screening and Monitoring of Encephalopathy/Delirium | OGLES, MATTHEW ERIC | 3791 | §101§112 | Non-Final OA | 133d overdue | Pending | Jun 16, 2023 |
| 18256593 | COMPOSITIONS COMPRISING MOLECULES FOR CYSTIC FIBROSIS TREATMENT | NGUYEN, JOHN P | 1619 | §103§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18032768 | METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE | PAK, JOHN D | 1699 | §102§103§112 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18031760 | PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS | WESTERBERG, NISSA M | 1618 | §103 | Non-Final OA | 53d | Pending | Apr 13, 2023 |
| 18120204 | MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF | MEYERING, SHABANA SHABBEER | 1635 | §101§112 | Non-Final OA | — | Pending | Mar 10, 2023 |
| 18107108 | COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS | LEITH, NANCY J | — | §103DP | Non-Final OA | — | Pending | Feb 08, 2023 |
| 17580129 | METHODS TO PREVENT, INHIBIT OR TREAT INTERVERTEBRAL DISC DEGENERATION | LEE, HOI YAN NMN | 1693 | §103 | Final Rejection | 5d overdue | Pending | Jan 20, 2022 |
| 17518301 | MULTIMODAL SENSORY STIMULATION | TRAN, JULIE THI | 3791 | §103 | Non-Final OA | 52d overdue | Pending | Nov 03, 2021 |
| 17503082 | MONITORING EFFICACY OF MAGNETIC AND ELECTRIC FIELDS USING BIOMARKERS | REDDY, SUNITA | 3791 | §103§112 | Final Rejection | 5d | Pending | Oct 15, 2021 |
| 17311088 | HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS | SABILA, MERCY HELLEN | 1654 | §102Other | Final Rejection | 18d overdue | Pending | Jun 04, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial